Immunosuppressive drugs.
Collier
S J
SJ
University of Cambridge, Department of Surgery, Addenbrooke's Hospital, UK.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D016377:Organ Transplantation; D011090:Polyenes / Q000627:therapeutic use; D012263:Ribonucleosides / Q000627:therapeutic use; D020123:Sirolimus; D016559:Tacrolimus
D000900:Anti-Bacterial Agents; D006146:Guanidines; D007166:Immunosuppressive Agents; D011090:Polyenes; D012263:Ribonucleosides; C010052:mizoribine; D009173:Mycophenolic Acid; C037258:gusperimus; D020123:Sirolimus; D016559:Tacrolimus